Dr Tom Sam is Director Global Regulatory CMC, Organon, a part of Schering-Plough Corporation, the Netherlands. Previous functions included Director of Organon's Pharmaceutics Sections on Solid and Novel Dosage Forms. He is an expert in scientific and regulatory development of solid dosage forms and long-acting contraceptive systems, including vaginal and subdermal systems. He is member of Organon’s PAT working group and Quality Risk Management platform. Tom holds a Ph.D. from Leiden University and a Master degree in Business Management from Groningen University, the Netherlands. Tom Sam is

• president of FIP's Industrial Pharmacy Section (www.industrialpharmacy.org),
  
• member of the WHO Expert Committee on Specifications of Pharmaceutical Preparations,
  
• past-president of the Netherlands Society for Pharmaceutical Sciences,
  
• organiser of the European Symposia on Controlled Drug Delivery,
  
• member of the AAPS Regulatory Sciences Section and the AAPS Manufacturing, Engineering & Quality Focus Group,
  
• co-organiser of the WHO/FIP Training Workshop on Pharmaceutical Development with focus on Pediatric Formulations, Mumbai India